ALI and ARDS remain a major problem in the ICU; in a recent publication, the incidence of ALI in the United States was reported to be 78.9/100,000 persons per year, with a mortality rate of ...

Among those with both ARDS and PH, 36.8% died in the hospital, which was higher than the in-hospital mortality rate of 24.6% observed among those with ARDS and without PH.

By David Bautz, PhD NASDAQ:EDSA READ THE FULL EDSA RESEARCH REPORT Business Update Update on EB05 Development in ARDS Edesa Biotech, Inc. (NASDAQ:EDSA) is developing EB05 (paridiprubart) as a ...

An initial trial suggests that a new drug, originally developed for use with cancer patients, could improve the survival of patients with acute respiratory distress syndrome (ARDS). The patients ...

Compared with those with ARDS alone, patients hospitalized with ARDS and PH were more likely to have: In-hospital mortality (36.8% vs 24.6%, adjusted OR 1.52, 95% CI 1.46-1.58) ...

ARDS is a life-threatening illness in which the lungs are severely inflamed. It has a number of possible causes, including sepsis and severe pneumonia.

ARDS is a life-threatening lung condition with multiple causes, including severe pneumonia and sepsis due to bacterial and viral infections such as influenza and SARS-CoV-2, ...